Cargando…
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing
BACKGROUND: Vascular invasion is an independent risk factors for recurrence and poor prognosis in patients with hepatocellular carcinoma (HCC). However, the molecular mechanisms of HCC vascular invasion are largely unknown. Deciphering the molecular changes associated with the vascular invasion proc...
Autores principales: | Li, Qi, Zhang, Qifan, Chen, Jinzhang, Zang, Mengya, Hu, Xiaoyun, Li, Rong, Hou, Jinlin, Zhou, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459210/ https://www.ncbi.nlm.nih.gov/pubmed/36092348 http://dx.doi.org/10.21037/jgo-22-556 |
Ejemplares similares
-
Next-Generation Sequencing Characterizes the Landscape of Somatic Mutations and Pathways in Metastatic Bile Tract Carcinoma
por: Li, Qi, et al.
Publicado: (2020) -
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis
por: Hu, Xiaoyun, et al.
Publicado: (2022) -
Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients
por: Ke, Lixin, et al.
Publicado: (2022) -
Interaction between hepatitis B virus infection and the efficacy of camrelizumab in combination with apatinib therapy in patients with hepatocellular carcinoma: a multicenter retrospective cohort study
por: Yuan, Guosheng, et al.
Publicado: (2021) -
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
por: Li, Qi, et al.
Publicado: (2022)